New consortium aims to comprehend principles underlying the formation of coronaviruses Kumar Jeetendra | December 10, 2020 “This consortium will aim to comprehend the physical principles underlying the formation of coronaviruses,” said Roya Zandi, a professor of physics and astronomy at UC Riverside and the principal investigator of this four-year project that received funding of over $1.75 million. “We will also explore the effect of some drugs on the assembly process.” Zandi …
Indian researchers recognize new potential drug medicines for COVID-19 Kumar Jeetendra | December 10, 2020 Indian scientists have identified drugs and possible cocktails that could target vital proteins of the novel coronavirus, and might possibly help treat COVID-19. Using a virtual screening of this DrugBank database, the study published in the journal Scientific Reports, identified a variety of as yet unexplored ways to attack SARS-CoV-2, even as it mutates. …
Estonia based Digital-health consultation provider “VIVEO” launches in India Kumar Jeetendra | December 10, 2020 Mumbai, Thursday, 10 December 2020: Estonia-based tech innovator VIVEO Health, a large integrated tele-health provider today announced the seamless expansion of its operations in India. The expansion falls in line with an increased demand due to the COVID-19 pandemic for remote consulting platforms specially designed for medical professionals with an urge to provide a safe …
Researchers give knowledge on how lung microorganisms secure against attacking microbes Kumar Jeetendra | December 9, 2020 New insight on how bacteria in the lungs protect against invading pathogens has been published today in the open-access eLife journal. The study in mice shows that a strain of lung bacteria called Lactobacillus provides a barrier against Streptococcus pneumoniae (S. pneumoniae) colonisation in animals previously infected with influenza A virus when applied therapeutically following …
Conceivable new anti-microbial created for drug-resistant pulmonary microorganism Kumar Jeetendra | December 9, 2020 Scientists from Johns Hopkins University and Medicine have developed a potential new antibiotic for a pathogen that is notoriously resistant to drugs and often lethal for people with cystic fibrosis and other lung disorders. The pathogen, called Mycobacterium abscessus, is related to some better-known bacterium that causes tuberculosis and leprosy but has recently emerged as …
Oxford-AstraZeneca vaccines is protected and compelling, peer-assessed study affirms Kumar Jeetendra | December 9, 2020 COVID-19 vaccines from Pfizer/BioNTech and Moderna have reported efficiency levels of more than 90 percent in late stage trials. Oxford University and AstraZeneca COVID-19 vaccine is safe and highly effective in preventing coronavirus disease, confirms data published in The Lancet, a medical journal, on December 8. Detailed results from the AstraZeneca/Oxford trials have been eagerly …
Study affirms most basic complexities related with COVID-19 Kumar Jeetendra | December 8, 2020 A large study of patients in america who contracted coronavirus disease 2019 (COVID-19) confirms many complications of the disease, according to new research in CMAJ (Canadian Medical Association Journal). Understanding the full range of associated conditions can aid in prognosis, guide treatment decisions and better inform patients as to their actual risks for the variety …
New industry partnership will advance digital application to benefit more people affected by Rheumatoid Arthritis (RA) Kumar Jeetendra | December 8, 2020 Copenhagen, Denmark – 08, December, 2020 –At Daman we are very excited to announce that we have signed a partnership agreement with leading pharmaceutical companies Gilead Sciences and Galapagos. The partnership agreement will include 15 markets globally. The purpose of the partnership agreement is to reach more people living with chronic disease Rheumatoid Arthritis (RA). …
CRISPR-based test could give fast, affordable testing to help control COVID-19 spread Kumar Jeetendra | December 7, 2020 Imagine swabbing your nostrils, putting the swab in a device, and obtaining a read-out on your mobile phone in 15 to 30 minutes which tells you if you’re infected with the COVID-19 virus. This has been the vision for a group of scientists at Gladstone Institutes, University of California, Berkeley (UC Berkeley), and University of …
Free radicals might be significant for the brain to stay versatile Kumar Jeetendra | December 6, 2020 Reactive oxygen molecules, also known as”free radicals”, are generally considered dangerous. Researchers from the German Center for Neurodegenerative Diseases (DZNE) and the Center for Regenerative Therapies Dresden (CRTD) at TU Dresden published the findings in the journal Cell Stem Cell. The researchers focused on the”hippocampus”, a brain region that is regarded as the control center …
Adar Poonawalla Of Serum Institute Among 6 Named ‘Asians Of The Year’ :Singapore Daily Kumar Jeetendra | December 5, 2020 Adar Adar Poonawalla, the chief executive of the world’s largest vaccine Maker Serum Institute of India, is among six people named”Asians of the Year” by Singapore’s leading daily, The Straits Times for their work in fighting the COVID-19 pandemic. Pune-based Serum Institute of India (SII) has collaborated with the University of Oxford and the British-Swedish …
ATCC presents new product with launch of SARS-CoV-2 external control unit Kumar Jeetendra | December 4, 2020 The ready-to-run kit provides controls in the rapidly changing COVID-19 testing landscape as a workflow-optimized kit with complete genome coverage that is widely compatible with most commercial and laboratory-developed tests. Federal regulation requires that clinical laboratories assess the performance of their testing applications. This new ATCC kit is a practical, kitted solution clinical laboratories can …
